Neuropsychopharmacology
- Early life stress in male mice blunts responsiveness in a translationally-relevant reward task3 years ago
- Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants3 years ago
- UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice3 years ago
- How should we design future mechanistic and/or efficacy clinical trials?3 years ago
- Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial3 years ago
- Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants3 years ago
- Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice3 years ago
Journal of Psychopharmacology
- Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys7 years ago
- EMD386088 (5 mg/kg) has no effect on latent inhibition shown to both light and noise stimuli7 years ago
- Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia7 years ago
- The mGluR2/3 agonist LY379268 reverses NMDA receptor antagonist effects on cortical gamma oscillations and phase coherence, but not working memory impairments, in mice7 years ago
- Caffeine improves text reading and global perception7 years ago
- Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial7 years ago
- Corrigendum to The Australian Drug Harms Ranking Study7 years ago
European Neuropsychopharmacology
- ‘Microbiota-metabolome interaction in depression: Could it be the new 42?’6 years ago
- Phenotypes of reinforcement sensitivity as predictors of the response to acute antidepressant treatment in rats6 years ago
- Gray matter reorganization underpinnings of antidepressant treatment of persistent depressive disorder6 years ago
- A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder6 years ago
- The “VIP-ADHD trial”: Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?6 years ago
- Contents6 years ago
- Editorial Board6 years ago